iBio Inc. (IBIO) shares surged over 12% premarket after the company announced a $26 million private placement with healthcare-focused institutional investors. iBio will sell more than 11 million shares at $2.35 each, with the transaction expected to close around January 13, 2026, pending customary conditions.